Literature DB >> 26830173

Risk factors for intensive care unit admission in patients with severe leptospirosis: a comparative study according to patients' severity.

Elizabeth De Francesco Daher1,2, Douglas Sousa Soares3, Anna Tereza Bezerra de Menezes Fernandes4, Marília Maria Vasconcelos Girão5, Pedro Randal Sidrim6, Eanes Delgado Barros Pereira7,8, Natalia Albuquerque Rocha9, Geraldo Bezerra da Silva10.   

Abstract

BACKGROUND: The aim of this study is to investigate predictive factors for intensive care unit (ICU) admission among patients with severe leptospirosis.
METHODS: This is a retrospective study with all patients with severe leptospirosis admitted to a tertiary hospital. Patients were divided in ICU and ward groups. Demographical, clinical and laboratory data of the groups were compared as well as acute kidney injury (AKI) severity, according to the RIFLE criteria (R = Risk, I = Injury, F = Failure, L = Loss, E = End-stage kidney disease).
RESULTS: A total of 206 patients were included, 83 admitted to ICU and 123 to ward. Mean age was 36 ± 15.8 years, with 85.9% males. Patients in ICU group were older (38.8 ± 15.7 vs. 34.16 ± 15.9 years, p = 0.037), had a shorter hospital stay (4.13 ± 3.1 vs. 9.5 ± 5.2 days, p = 0.0001), lower levels of hematocrit (29.6 ± 6.4 vs. 33.1 ± 8.6%, p = 0.003), hemoglobin (10.2 ± 2.4 vs. 11.6 ± 1.9 g/dL, p < 0.0001), and platelets (94,427 ± 86,743 vs. 128,896 ± 137,017/mm(3), p = 0.035), as well as higher levels of bilirubin (15.0 ± 12.2 vs. 8.6 ± 9.5 mg/dL, p = 0.001). ICU group also had a higher frequency of severe AKI (RIFLE-"Failure": 73.2% vs. 54.2%, p < 0.0001) and a higher prevalence of dialysis requirement (57.3% vs. 27.6%, p < 0.0001). Mortality was higher among ICU patients (23.5% vs. 5.7%, p < 0.0001). Independent predictors for ICU admission were tachypnea (p = 0.027, OR = 13, CI = 1.3-132), hypotension (p = 0.009, OR = 5.27, CI = 1.5-18) and AKI (p = 0.029, OR = 14, CI = 1.3-150). Ceftriaxone use was a protective factor (p = 0.001, OR = 0.13, CI = 0.04-0.4).
CONCLUSIONS: Independent risk factors for ICU admission in leptospirosis include tachypnea, hypotension and AKI. Ceftriaxone was a protective factor for ICU admission, suggesting that its use may prevent severe forms of the disease.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26830173      PMCID: PMC4736552          DOI: 10.1186/s12879-016-1349-x

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


Background

Leptospirosis is one of the most important zoonosis in the world [1]. The disease may manifest as a broad spectrum of signs and symptoms, with a sudden onset of headache, high-degree fever, malaise, myalgia, conjunctival suffusion and transient rash [1]. The severe form is characterized by jaundice, acute kidney injury (AKI) and hemorrhage, particularly in the lungs, known as Weil’s disease [1, 2]. It is mainly caused by serovars Icterohaemorrhagiae, Copenhageni, Lai and others [1, 2]. Mortality from severe leptospirosis is high, ranging from 5 to 20 %, even when optimal treatment is provided3. Leptospirosis-associated AKI has peculiar characteristics: it is usually non-oliguric and associated with hypokalemia or normokalemia [1, 3, 4]. Intensive Care Unit (ICU) admission is often necessary for patients with severe leptospirosis. In a recent Brazilian study, leptospirosis was among the most frequent infectious diseases that required ICU [5]. Mortality rates remain high, despite of treatments instituted [3, 6]. It was demonstrated that early dialysis reduces mortality and complications associated with leptospirosis in the ICU [7]. Early identification of severe or potentially severe cases of leptospirosis, and then possible ICU admission need, is of crucial importance to enhance more aggressive treatment and decrease mortality, which is still unacceptable high in this disease. As leptospirosis is endemic in many tropical and developing countries, a more adequate classification and approach to patients can probably impact on economic issues. A mortality decrease in leptospirosis, for example, is favorable to labor, once great part of leptospirosis patients are young man, and it is possible to avoid years of life lost. Hence, the aim of this study was to investigate predictive factors for ICU admission among patients with severe leptospirosis.

Methods

Studied population

The study included all patients with confirmed diagnosis of severe leptospirosis (Weil’s disease) consecutively admitted to São José Infectious Diseases Hospital, in Northeast Brazil, from 2000 to 2013. Study Design This is a cross-sectional study. Data on hospital admission were obtained from medical records. They were initially admitted to the emergency department, and then transferred to another unit (ward or ICU). We also grouped these patients according to the site of care: those transferred to the ICU and to ward. A comparison of demographical, clinical and laboratory data between the two groups was performed in order to investigate differences between them and factors associated with ICU admission.

Case definition

Leptospirosis cases were defined as the presence of positive serology through microscopic agglutination test (MAT) higher than 1:800. All patients had also epidemiological and clinical history compatible with leptospirosis.

Inclusion criteria

Inclusion criteria were: patients ≥ 18 years-old, positive serology for leptospirosis, admission at São José Infectious Diseases Hospital during the study period.

Exclusion criteria

Exclusion criteria were: patients ≤ 18 years-old, negative serology for leptospirosis, incomplete data on medical records, referral to other hospitals and hospital stay less than 24 h.

Studied parameters

Demographic characteristics such as age, gender, time between initial symptoms and hospital admission as well as length of hospital stay were recorded. The clinical investigation included a record of all clinical signs and symptoms presented by each patient on hospital admission and during hospital stay, medications used, dialysis requirement and co-infections. Laboratory data on hospital admission included an assessment of serum urea, creatinine, sodium, potassium, total bilirubin, direct bilirubin, indirect bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH), hemoglobin, hematocrit, leukocyte count, platelets count and arterial blood gas analysis.

Definitions

Acute kidney injury (AKI) was defined according to RIFLE criteria (R = Risk, I = Injury, F = Failure, L = Loss, E = End-stage kidney disease) [8]. Thrombocytopenia was defined as platelets count lower than 150,000/mm3 and anemia as hemoglobin <12 g/dL. The occurrence of metabolic acidosis was considered when pH < 7.35 and HCO3 < 20 mEq/L, and severe metabolic acidosis when pH < 7.10. Tachypnea was defined as a respiratory rate higher than 25 per minute. Oliguria was defined as urine output < 400 ml/day after 24 h of effective hydration. Hypotension was defined as mean arterial blood pressure (MAP) < 60 mmHg, and therapy with vasoactive drugs was initiated when MAP remained lower than 60 mmHg despite the use of endovenous fluids. Hypertension was defined as systolic pressure ≥130 mmHg and/or diastolic pressure ≥85 mmHg.

Statistical analysis

The results were expressed through tables, mean ± standard deviation (SD). All data were analyzed with the program SPSS version 20.0 (Chicago, IL, USA). Comparison between the two groups was performed using Pearson’s Chi-square test and Student’s T test. Mann–Whitney test was used for parameters with a non-normal distribution. A logistic regression model was used for quantitative variables. Adjusted odds ratios (OR) and 95 % confidence intervals (CI) were calculated. A multivariate logistic regression was performed to analyze the possible risk factors associated with ICU admission. The parameters included in the multivariate model were those that showed a significance level in the univariate analysis. Significance level was set at 5 % (p values ≤ 0.05).

Ethics

The protocol of this study was approved by the Ethics Committee of São José Infectious Diseases Hospital, Fortaleza, Ceará, Brazil.

Results

Patients’ characteristics

Among 206 patients included in the study, eighty-three were included in the ICU group and 123 in the ward group. There was a predominance of males (85.9 %), and mean age was 36 ± 15.8 years. Complete evaluation of demographic data is presented in Table 1.
Table 1

Comparison of demographic data between patients with severe leptospirosis admitted to ICU and ward

ICU (N = 83)Ward (N = 123) p
Age (years)38.8 ± 15.734.1 ± 15.90.037
Gender
 Male72 (86.7 %)105 (85.4 %)0.840
 Female11 (13.3 %)18 (14.6 %)
Hospital stay (days)4.13 ± 3.19.5 ± 5.20.0001
Time between onset of symptoms and hospitalization (days)7 ± 47.22 ± 4.110.224
Mortality (%)23.55.7<0.0001

Pearson’s Chi-square test, T-Student test and Mann–Whitney test were used to perform this comparison. P values ≤ 0.05 were considered statistically significant

Comparison of demographic data between patients with severe leptospirosis admitted to ICU and ward Pearson’s Chi-square test, T-Student test and Mann–Whitney test were used to perform this comparison. P values ≤ 0.05 were considered statistically significant

Signs and symptoms at admission

Main signs and symptoms at hospital admission were fever (87.1 %), myalgia (77.2 %), jaundice (71.7 %), headache (65.5 %), calf pain (48.5 %), asthenia (45.0 %) and diarrhea (41.5 %). Higher levels of heart and respiratory rates were observed in ICU group (105.0 ± 19.5 vs. 94.7 ± 19.0/min, p = 0.008; 31.8 ± 13.0 vs. 25.0 ± 8.8/min, p = 0.004, respectively), as well as lower levels of systolic blood pressure (106.3 ± 27 vs. 115.2 ± 18 mmHg, p = 0.018), as summarized in Table 2.
Table 2

Comparison of signs, symptoms and vital signs among patients with severe leptospirosis admitted to ICU and ward

ICU (N = 48)Ward (N = 123) p
Signs and symptoms
 Choluria7 (16.6 %)54 (44.7 %)0.001
 Crackles1 (2.1 %)15 (13 %)0.043
 Diarrhea12 (25 %)52 (42.3 %)0.855
 Dyspnea18 (37.5 %)33 (27.6 %)0.287
 Fever33 (68.8 %)115 (94.3 %)<0.0001
 Hematemesis7 (14.6 %)7 (5.7 %)0.068
 Hematuria3 (8.3 %)8 (7.3 %)0.759
 Hemoptysis8 (16.7 %)9 (8.1 %)0.625
 Jaundice30 (64.5 %)87 (71.5 %)0.998
 Myalgia27 (58.3 %)104 (84.6 %)<0.0001
 Oliguria10 (22.9 %)32 (26.8 %)0.699
 Conjunctival suffusion4 (10.4 %)22 (17.9 %)0.305
 Tachypnea15 (33.3 %)15 (13 %)0.004
Vital signs
 SBP (mmHg)106.28 ± 27115.17 ± 180.018
 DBP (mmHg)64.53 ± 18.771.3 ± 14.80.18
 HR (/min)105.03 ± 19.594.7 ± 19.050.008
 RR (/min)31.8 ± 1325 ± 8.780.004

SBP systolic blood pressure, DBP diastolic blood pressure, HR Heart Rate, RR Respiratory Rate. Pearson’s Chi-squared test, T-Student test and Mann–Whitney test were used. P values ≤ 0.05 were considered statistically significant

Comparison of signs, symptoms and vital signs among patients with severe leptospirosis admitted to ICU and ward SBP systolic blood pressure, DBP diastolic blood pressure, HR Heart Rate, RR Respiratory Rate. Pearson’s Chi-squared test, T-Student test and Mann–Whitney test were used. P values ≤ 0.05 were considered statistically significant

Comparison between ICU and ward group

Patients in the ICU group were older than ward group (38.8 ± 15.7 vs. 34.2 ± 15.9 years, p = 0.037). Average length of hospital stay was shorter in the ICU group (4.13 ± 3.1 vs. 9.5 ± 5.2 days, p = 0.001). Patients admitted to ICU also presented lower levels of hematocrit (29.6 ± 6.4 vs. 33.1 ± 8.6 %, p = 0.003), hemoglobin (10.2 ± 2.4 vs. 11.6 ± 1.9 g/dL, p < 0.0001), platelets (94,427 ± 86,743 vs. 128,896 ± 137,017/mm3, p = 0.035), as well as higher levels of total bilirubin, direct and indirect bilirubin (15.0 ± 12.2 vs. 8.6 ± 9.5 mg/dL, p = 0.001; 9.2 ± 8.5 vs. 5.9 ± 7.1 mg/dL, p = 0.018; 4.5 ± 6.1 vs. 2.4 ± 3.2 mg/dL, p = 0.013, respectively) on hospital admission, as summarized in Table 3. ICU patients also presented higher prevalence of hypertension (68.0 vs. 43.9 %, p = 0.006), hypotension (66.0 vs. 33.3 %, p < 0.0001), metabolic acidosis (60.5 vs. 36.5 %, p = 0.011) and severe metabolic acidosis (11.0 vs. 0 %, p = 0.02) on hospital admission.
Table 3

Comparison of laboratory data between patients with severe leptospirosis admitted to ICU and wards

ParametersICUNon-ICU p
N = 83 N = 123
Creatinine (mg/dl)3.97 ± 2.252.97 ± 2.40.004
Urea (mg/dl)131.8 ± 68101.2 ± 72.50.004
Potassium (mEq/L)3.91 ± 0.853.9 ± 1.070.951
Sodium (mEq/L)133 ± 6.61130 ± 190.317
AST (UI/L)169.8 ± 199132.13 ± 1830.285
ALT (UI/L)101.83 ± 90101.90 ± 1530.998
LDH (UI/L)810.25 ± 539671.94 ± 4200.416
Total bilirubin (mg/dl)15 ± 12.28.6 ± 9.50.001
Direct bilirubin (mg/dl)9.2 ± 8.55.9 ± 7.110.018
Indirect bilirubin (mg/dl)4.48 ± 6.082.38 ± 3.220.013
Hematocrit (%)29.6 ± 6.433.1 ± 8.630.003
Hemoglobin (g/dl)10.2 ± 2.411.6 ± 1.95<0.001
WBC (103/mm3)14.30 ± 7.7014.95 ± 1.820.772
Platelets (103/mm3)94.42 ± 86.74128.89 ± 137.010.035
pO2 (mmHg)87.3 ± 3283 ± 340.542
pCO2 (mmHg)31.81 ± 9.432.64 ± 8.50.636
pH7.35 ± 0.087.36 ± 0.070.127
Bicarbonate (mEq/L)17.89 ± 4.8218.8 ± 4.890.330
SaO2 (%)93.82 ± 5.791.6 ± 10.170.190

AST aspartate aminotransferase, ALT alanine aminotransferase, LDH lactate dehydrogenase, WBC white blood cells, PO O2 partial pressure, PCO PCO2 partial pressure, SaO O2 saturation

Chi-squared test, T-Student test and Mann–Whitney test were used to perform this comparison. Values expressed as mean ± SD and percentage. P values ≤ 0.05 were considered statistically significant

Comparison of laboratory data between patients with severe leptospirosis admitted to ICU and wards AST aspartate aminotransferase, ALT alanine aminotransferase, LDH lactate dehydrogenase, WBC white blood cells, PO O2 partial pressure, PCO PCO2 partial pressure, SaO O2 saturation Chi-squared test, T-Student test and Mann–Whitney test were used to perform this comparison. Values expressed as mean ± SD and percentage. P values ≤ 0.05 were considered statistically significant ICU group had higher levels of serum creatinine (3.97 ± 2.25 vs. 2.97 ± 2.4 mg/dL, p = 0.004) and serum urea (131.8 ± 68 vs. 101.2 ± 72.5 mg/dL, p = 0.004) on hospital admission. Oliguria was not significantly different between ICU group and ward group (22.9 % v. 26.8 %, p = 0.699, respectively). The ICU group also presented higher prevalence of AKI (93.9 % vs. 69.9 %, p < 0.0001), with a higher number of severe forms according to RIFLE criteria (“Risk” 4.9 % vs. 7.5 %, “Injury” 17.1 % vs. 10.0 % e “Failure” 73.2 % vs. 54.2 %, p < 0.0001). Need of dialysis was more frequent in this group (57.3 % vs. 27.6 %, p < 0.0001) when compared to ward group, as presented in Table 4.
Table 4

Comparison of acute kidney injury and dialysis requirement between patients with severe leptospirosis admitted to ICU and wards

ICU (N = 83)Ward (N = 123) p
AKI77 (93.9 %)85 (69.9 %)<0.0001
Dialysis47 (57.3 %)33 (27.6 %)<0.0001
RIFLE
 Risk3 (4.9 %)9 (7.5 %)
 Injury14 (17.1 %)12 (10 %)<0.0001
 Failure60 (73.2 %)66 (54.2 %)

Chi-square test was performed to make this comparison. P values ≤ 0.05 were considered statistically significant

Comparison of acute kidney injury and dialysis requirement between patients with severe leptospirosis admitted to ICU and wards Chi-square test was performed to make this comparison. P values ≤ 0.05 were considered statistically significant

Treatment

Need of vasoconstrictors and use of diuretics were higher in ICU group (57.8 vs. 12.3 %, p < 0.0001; 49.4 vs. 26.1 %, p = 0.006, respectively). Ceftriaxone use was significantly higher in the ward group (67.6 vs. 41 %, p = 0.009), while the use of crystalline penicillin was similar in both groups, as summarized in Table 5.
Table 5

Comparison of treatments instituted for patients with severe leptospirosis admitted to ICU and ward

ICU (N = 83)Ward (N = 123) p
Hemoderivatives44 (54 %)58 (47.7 %)0.052
Vasoconstrictors47 (57.8 %)15 (12.3 %)<0.0001
Ceftriaxone34 (41 %)83 (67.6 %)0.009
Penicillin48 (59 %)60 (49.1 %)0.354
Diuretics41 (49.4 %)32 (26.1 %)0.006

Pearson’s Chi-squared test was used to make the comparison. P values ≤ 0.05 were considered statistically significant

Comparison of treatments instituted for patients with severe leptospirosis admitted to ICU and ward Pearson’s Chi-squared test was used to make the comparison. P values ≤ 0.05 were considered statistically significant

Risk factors for ICU admission

In multivariate analysis, independent predictors for ICU admission were: tachypnea (p = 0.027, OR: 13, CI = 1.3 - 132), hypotension (p = 0.009, OR: 5.27, CI = 1.5 - 18) and AKI severity (p = 0.029, OR: 14, CI = 1.3 - 150). On the other hand, ceftriaxone use was a protective factor (p = 0.001, OR = 0.13, CI = 0.04 – 0.4) for ICU admission, as described in Table 6.
Table 6

Independent risk factors for ICU admission among patients with severe leptospirosis (multivariate analysis)

Multivariate analysis p OR/ 95 % CI
Tachypnea0.02713 (1.3 – 132)
Hypotension0.0095.27 (1.5 – 18)
AKI0.02914 (1.3 – 150)
Ceftriaxone0.0010.13 (0.04-0.4)

OR odds ratio. 95 % CI: 95 % confidence interval. Logistic regression and multivariate analysis were performed to make this comparison. P values ≤ 0.05 were considered statistically significant

Independent risk factors for ICU admission among patients with severe leptospirosis (multivariate analysis) OR odds ratio. 95 % CI: 95 % confidence interval. Logistic regression and multivariate analysis were performed to make this comparison. P values ≤ 0.05 were considered statistically significant

Mortality

Overall mortality was 12.7 %, and it was higher in ICU group (23.5 vs. 5.7 %, p < 0.0001).

Discussion

Predictors for ICU admission among patients with severe leptospirosis include tachypnea, hypotension and severe AKI, which can be identified at hospital admission and then subside requirement for a more aggressive treatment. The use of ceftriaxone was a protective factor against ICU admission, which suggests an important effect on decreasing disease severity. Leptospirosis is a public health problem, with higher prevalence in tropical areas, including Brazil [4, 9]. The disease can present with severe manifestations and high mortality. Therefore it is important to characterize predictors of intensive care need in order to early identify potentially fatal cases and to provide a more careful approach. This is the first study in our region to investigate the differences between patients with leptospirosis admitted to a ward service and ICU. In the present study patients admitted to the ICU were older, which may reflect an association between advanced age and disease severity, as previously reported [10-12]. In a recent study from India, older age was a predictor of mortality in leptospirosis [3]. Leptospirosis in elderly patients was associated with severe course and increased risk of mortality, mostly due to the high incidence of comorbidities in this population [12]. The length of hospital stay was shorter in ICU patients, and this is probably due to a high mortality in cases that demand intensive care. We observed that more critically ill patients usually died during the first days of ICU admission, despite early treatment. Previous studies have shown that early daily dialysis in patients with leptospirosis-associated AKI reduces mortality and, therefore, it would probably be beneficial in critically ill patients [7, 13]. In the present study, ICU patients presented higher levels of total, direct and indirect bilirubin than ward patients. In a French study with leptospirosis patients, bilirubinemia was higher in severe cases and jaundice was demonstrated to be a predictive factor of severity in leptospirosis according to multivariate analysis (p = 0.005, OR = 10.1, CI = 1.79 – 56.8) [14]. In this same study, dyspnea (respiratory rate > 24/min) was higher in severe cases (p < 0.0001). These findings confirm the data in our study and reinforce the role of tachypnea as independent predictor for ICU admission, according to multivariate analysis. We have found higher prevalence of anemia and thrombocytopenia as well as higher levels of urea and creatinine in the ICU group. Thrombocytopenia is frequent in leptospirosis and contributes to hemorrhagic phenomena [2, 15]. Although rare, pancytopenia can also be found in leptospirosispatients [16], but when it occurs other diagnosis must be investigated, such as hematologic disorders and visceral leishmaniasis, especially in tropical countries. In a recent study conducted in our region with 374 leptospirosis patients, thrombocytopenia was found in 53.5 % of patients on admission and it was associated with length of disease and AKI, but it was not associated with higher mortality [15]. Oliguria is a frequent feature in patients with severe AKI and it is associated with more frequent pulmonary involvement and higher mortality in leptospirosis [2, 13, 17–20]. However, in the present study, oliguria was not associated with ICU admission, since there was no significant difference in frequency of oliguria between the two groups. Several hemodynamic changes that occur in leptospirosis, such as systemic vasodilation, renal vasoconstriction and elevation of aldosterone, associated with dehydration secondary to fever, vomiting and diarrhea could explain the onset of oliguria in leptospirosis patients [4, 21]. Hypotension was found to be a predictor of ICU admission in our study, according to multivariate analysis. Hemodynamic changes, such as increased vascular permeability secondary to cytokines and vasoactive mediators might also explain the onset of hypotension in severe cases. Low mean arterial pressure is well described as an important factor for the onset of AKI and disease severity in leptospirosis patients [22]. It is known that AKI severity in leptospirosis is associated with higher mortality [17, 23]. RIFLE and AKIN are good markers for the purpose of stratifying patients’ severity in leptospirosis. Worse AKI stages (RIFLE-F and AKIN-3) are associated with higher mortality [17]. In the present study, AKI RIFLE “Failure” was significantly higher in the ICU group. The most recognized factors correlating with severity in leptospirosis are AKI, pulmonary involvement and electrolyte imbalances [24]. In the present study, independent risk factors associated with ICU admission were hypotension, tachypnea and AKI severity. In a recent study with 176 leptospirosis patients, independent predictors of severity were current cigarette smoking (OR  =  2.94 [CI 1.45-5.96]), delay >2 days between the onset of symptoms and the initiation of antibiotic therapy (OR  =  2.78 [CI 1.31-5.91]) and Leptospira interrogans serogroup Icterohaemorrhagiae as the infecting strain (OR  =  2.79 [CI 1.26-6.18]) [25]. Another study, conducted with 101 leptospirosis patients in India, showed that older age, delayed antibiotic therapy, higher bilirubin, aspartate aminotransferase, alkaline phosphatase, leucocyte count and aspartate/alanine aminotransferase ratio (AAR) were univariate predictors of mortality. Ceftriaxone use was more frequent among patients admitted to ward and it was shown to be a protective factor for ICU admission, different from penicillin use, which was not different between groups. The use of antibiotics in leptospirosis has been widely debated. Numerous studies have been conducted to investigate the role of antibiotics in leptospirosis, with controversial results, and the current consensus is that antibiotics must be used, since it probably brings more benefits than harm, reducing the time of hospital stay, the duration of fever and slowing disease symptoms in general [26-30]. It is possible that antibiotics have an important role in immune response modulation in leptospirosis, which could partially explain the observation of a better evolution in patients treated with penicillin [31-33]. Nonetheless, mortality does not seem to be significantly influenced by antibiotic use [34]. As expected, in the present study, mortality was higher among ICU patients (23.5 % vs. 5.7 %, p < 0.0001) when compared to ward group. Some studies performed in our region have found mortality rates varying from 12 to 20 % in leptospirosis, which were lower than those found in the present study [35]. Even higher mortality rates have been described in some cases. In a study performed with 60 leptospirosis ICU patients between 2002 and 2003, mortality was 52 %, which was remarkably higher than average mortality in that ICU in the period [36]. These data reinforce the importance of determining predictors of ICU admission in leptospirosis.

Conclusion

Tachypnea, hypotension and AKI are risk factors for ICU admission, and ceftriaxone use is a protective factor. These results alert to early identification of the above mentioned factors and then a more aggressive treatment, including early antibiotics use and renal replacement therapy when needed to possibly decrease mortality.

Study limitations

Main limitations of this study derive from its retrospective nature. Some data from patient’s records were not available on admission. Urine output and urinalysis were particularly poorly available in the ward group, since non-critical care units frequently do not accurately measure and analyze urine output. Further prospective studies are then necessary to continue the investigation of leptospirosis predictors of ICU admission.
  36 in total

Review 1.  Leptospirosis: a zoonotic disease of global importance.

Authors:  Ajay R Bharti; Jarlath E Nally; Jessica N Ricaldi; Michael A Matthias; Monica M Diaz; Michael A Lovett; Paul N Levett; Robert H Gilman; Michael R Willig; Eduardo Gotuzzo; Joseph M Vinetz
Journal:  Lancet Infect Dis       Date:  2003-12       Impact factor: 25.071

Review 2.  Leptospirosis.

Authors:  Andrew Slack
Journal:  Aust Fam Physician       Date:  2010-07

Review 3.  Definition and classification of acute kidney injury.

Authors:  John A Kellum; Rinaldo Bellomo; Claudio Ronco
Journal:  Nephron Clin Pract       Date:  2008-09-18

4.  Evaluation of penicillin therapy in patients with leptospirosis and acute renal failure.

Authors:  E F Daher; C B Nogueira
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2000 Nov-Dec       Impact factor: 1.846

5.  Predictors of mortality in leptospirosis: an observational study from two hospitals in Kolkata, eastern India.

Authors:  Rudra P Goswami; Rama P Goswami; Ayan Basu; Santanu Kumar Tripathi; Sanghamitra Chakrabarti; Indrajit Chattopadhyay
Journal:  Trans R Soc Trop Med Hyg       Date:  2014-10-30       Impact factor: 2.184

6.  An assessment of the RIFLE criteria for acute renal failure in hospitalized patients.

Authors:  Shigehiko Uchino; Rinaldo Bellomo; Donna Goldsmith; Samantha Bates; Claudio Ronco
Journal:  Crit Care Med       Date:  2006-07       Impact factor: 7.598

7.  Developing a clinically relevant classification to predict mortality in severe leptospirosis.

Authors:  Senaka Rajapakse; Chaturaka Rodrigo; Rashan Haniffa
Journal:  J Emerg Trauma Shock       Date:  2010-07

Review 8.  Leptospira and leptospirosis.

Authors:  Ben Adler; Alejandro de la Peña Moctezuma
Journal:  Vet Microbiol       Date:  2009-03-13       Impact factor: 3.293

9.  Door-to-dialysis time and daily hemodialysis in patients with leptospirosis: impact on mortality.

Authors:  Lúcia Andrade; Sérgio Cleto; Antonio C Seguro
Journal:  Clin J Am Soc Nephrol       Date:  2007-06-20       Impact factor: 8.237

10.  Ceftriaxone compared with sodium penicillin g for treatment of severe leptospirosis.

Authors:  Thanachai Panaphut; Somnuek Domrongkitchaiporn; Asda Vibhagool; Bandit Thinkamrop; Wattanachai Susaengrat
Journal:  Clin Infect Dis       Date:  2003-06-06       Impact factor: 9.079

View more
  8 in total

1.  Severe leptospirosis in Morocco: comparative data from the Amazonian area.

Authors:  Loïc Epelboin; Paul Le Turnier; Emilie Mosnier; Roxane Schaub; Erwann Fontaine; Stéphanie Houcke; Anne Jolivet; Magalie Demar; Mathieu Nacher; Félix Djossou
Journal:  Intensive Care Med       Date:  2017-09-05       Impact factor: 17.440

2.  Predictors of lethality in severe leptospirosis in Transcarpathian region of Ukraine.

Authors:  Pavlo Petakh; Andriy Nykyforuk
Journal:  Infez Med       Date:  2022-06-01

3.  The Applicability of Commonly Used Severity of Illness Scores to Tropical Infections in Australia.

Authors:  Kris Salaveria; Simon Smith; Yu-Hsuan Liu; Richard Bagshaw; Markus Ott; Alexandra Stewart; Matthew Law; Angus Carter; Josh Hanson
Journal:  Am J Trop Med Hyg       Date:  2021-10-18       Impact factor: 3.707

4.  Severe leptospirosis in non-tropical areas: a nationwide, multicentre, retrospective study in French ICUs.

Authors:  Arnaud-Félix Miailhe; Emmanuelle Mercier; Adel Maamar; Jean-Claude Lacherade; Aurélie Le Thuaut; Aurélie Gaultier; Pierre Asfar; Laurent Argaud; Antoine Ausseur; Adel Ben Salah; Vlad Botoc; Karim Chaoui; Julien Charpentier; Christophe Cracco; Nicolas De Prost; Marie-Line Eustache; Alexis Ferré; Elena Gauvin; Suzanne Goursaud; Maximilien Grall; Philippe Guiot; Maud Jonas; Fabien Lambiotte; Mickael Landais; Jérémie Lemarié; Olivier Lesieur; Claire Lhommet; Philippe Michel; Yannick Monseau; Sébastien Moschietto; Saad Nseir; David Osman; Jérome Pillot; Gaël Piton; Nicholas Sedillot; Michel Sirodot; Didier Thevenin; Lara Zafrani; Yoann Zerbib; Pascale Bourhy; Jean-Baptiste Lascarrou; Jean Reignier
Journal:  Intensive Care Med       Date:  2019-10-25       Impact factor: 17.440

5.  An Observational Study of Human Leptospirosis in Seychelles.

Authors:  Leon Biscornet; Jeanine de Comarmond; Jastin Bibi; Patrick Mavingui; Koussay Dellagi; Pablo Tortosa; Frédéric Pagès
Journal:  Am J Trop Med Hyg       Date:  2020-09       Impact factor: 2.345

6.  Pancreatitis as a severe complication of leptospirosis with fatal outcome: a case report.

Authors:  Pedro Eduardo Andrade de Carvalho Gomes; Sávio de Oliveira Brilhante; Rachel Bezerra Carvalho; Daniel Ribeiro de Sousa; Elizabeth De Francesco Daher
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2019-12-20       Impact factor: 1.846

7.  Leptospirosis in Intensive Care Unit.

Authors:  Niteen D Karnik; Aditi S Patankar
Journal:  Indian J Crit Care Med       Date:  2021-05

8.  Arrhythmias in leptospirosis-associated acute kidney injury: a case series.

Authors:  Douglas de Sousa Soares; Gabriela Studart Galdino; Bruna Custódio Rodrigues; Geraldo Bezerra da Silva Junior; Elizabeth De Francesco Daher
Journal:  Braz J Infect Dis       Date:  2016-12-30       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.